Valued at a market cap of $181.1 billion, Thermo Fisher Scientific Inc. (TMO) is a global provider of life sciences solutions, analytical instruments, specialty diagnostics, and laboratory products and biopharma services, serving customers across North America, Europe, Asia-Pacific, and other international markets. It supports scientific research, drug development, clinical diagnostics, and laboratory operations worldwide.
Companies valued at $10 billion or more are generally classified as “large-cap” stocks, and Thermo Fisher Scientific fits this criterion perfectly. It operates through four business segments: Life Sciences Solutions; Analytical Instruments; Specialty Diagnostics; and Laboratory Products and Biopharma Services, offering a wide range of products and services for research, healthcare, and industrial applications.